William Lay
Chief Executive Officer chez MELODIOL GLOBAL HEALTH LIMITED
Fortune : 2 038 $ au 31/03/2024
Profil
Mr. William Lay is a Chief Executive Officer, Director & MD at Melodiol Global Health Ltd.
and a Group Chief Executive Officer at Creso Pharma US, Inc. He is on the Board of Directors at Melodiol Global Health Ltd.
Mr. Lay was previously employed as an Associate Director by Canopy Growth Corp.
and a Chief Strategy Officer & Executive Vice President by Red Light Holland Corp.
He received his undergraduate degree from Queen's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/01/2023 | 625 000 ( 0,15% ) | 2 038 $ | 31/03/2024 |
Postes actifs de William Lay
| Sociétés | Poste | Début |
|---|---|---|
| MELODIOL GLOBAL HEALTH LIMITED | Chief Executive Officer | 17/01/2022 |
Creso Pharma US, Inc.
 Creso Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Creso Pharma US, Inc. is based in DE. Part of Melodiol Global Health Ltd., Creso Pharma US, Inc. is an American pharmaceutical company. William Lay has been the CEO of the company since 2021. | Chief Executive Officer | 01/01/2022 |
Anciens postes connus de William Lay
| Sociétés | Poste | Fin |
|---|---|---|
| CANOPY GROWTH CORPORATION | Corporate Officer/Principal | 01/09/2020 |
| RED LIGHT HOLLAND CORP | Corporate Officer/Principal | - |
Formation de William Lay
| Queen's University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CANOPY GROWTH CORPORATION | Process Industries |
| MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
| RED LIGHT HOLLAND CORP | Process Industries |
| Entreprise privées | 1 |
|---|---|
Creso Pharma US, Inc.
Creso Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Creso Pharma US, Inc. is based in DE. Part of Melodiol Global Health Ltd., Creso Pharma US, Inc. is an American pharmaceutical company. William Lay has been the CEO of the company since 2021. | Health Technology |
